Electroceuticals/Bioelectric Medicine Market Revenue will Jump Up $35.5 Billion By 2025
“Rising geriatric population is the major factor that is expected to propel growth during the forecast period. Technological advancements in these products propel their adoption in treatment of chronic diseases such as cardiac arrhythmias and Parkinson's disease.�
The global Electroceuticals/Bioelectric Medicine Market is expected to reach USD 35.5 billion by 2025, according to a new report by Grand View Research, Inc. Rising geriatric population is the major factor that is expected to propel growth during the forecast period. Aging population is prone to various diseases such as cardiac arrhythmias, Parkinson's disease, Alzheimer's disease, epilepsy, and depression. There are various advanced electroceuticals including implantable cardioverter defibrillators, cochlear implants, cardiac pacemakers, and spinal cord stimulators, which can be used for the treatment of these conditions. Access Full Research Report on Global Electroceuticals/Bioelectric Medicine Market : http://www.grandviewresearch.com/industry-analysis/electroceuticalsbioelectric-medicine-market
Follow Us:
Increasing investment in the development of advanced bioelectric medicine is another major factor supporting the growth of the electroceuticals market. For instance, in FY 2016, Medtronic, a leading bioelectric medicine manufacturer, invested around USD 2,224 million in R&D for development of advanced products. Technological advancements in these products propel their adoption in treatment of chronic diseases such as cardiac arrhythmias and Parkinson's disease. The technological advanced electroceuticals provide high reliability and efficiency during treatment. Further key findings from the study suggest:
Implantable cardioverter defibrillators segment was the largest revenuegenerating segment of the electroceuticals market in 2016 owing to large application of these products for the treatment of arrhythmia
The implantable electroceuticals devices segment accounted for the largest revenue share in the bioelectric medicine market in 2016 owing to technological advancements
In the application segment, the arrhythmia segment accounted for the largest share in 2016 and is expected to maintain its dominance throughout forecast period
The hospitals dominated the electroceuticals market in terms of revenue in 2016 due to the escalating number of electroceutical devices implant procedures in hospitals
The North America bioelectric medicine market is the leading regional sector and accounted for the largest revenue share in 2016 mainly due to the existence of large number of medical devices companies in this region
The Asia Pacific region is expected to grow at a highest growth rate during the study period. The developing healthcare infrastructure and rising healthcare awareness in the Asian countries such as China and India is a major factor contributing to the growth in this region
Some of the major players include Medtronic; St. Jude Medical; Boston Scientific Corporation; Cochlear Ltd.; Sonova; LivaNova PLC; Biotronik; Nevro Corp.; SECOND SIGHT; and electroCore LLC.
Follow Us:
Grand View Research has segmented the global Electroceuticals Market on the basis of product, type, application, end-use, and region: Read Our Blogs on Reports from this category By Grand View Research: http://www.grandviewresearch.com/blogs/healthcare Table of Content of Global Electroceuticals Market Research Report: Chapter 1 Research Methodology 1.1 Country Wise Market: Base Estimates 1.2 Global Market: CAGR Calculation 1.3 Region Based Segment Share Calculation 1.4 Research Scope & Assumptions 1.5 List of Data Sources 1.5.1 Data for primary interviews, by sources 1.5.2 Data for primary interviews, by region Chapter 2 Executive Summary 2.1 Market Snapshot Chapter 3 Electroceuticals/Bioelectric Medicine Market Variables, Trends & Scope 3.1 Market Segmentation & Scope 3.2 Market Driver Analysis 3.2.1 Rising geriatric population 3.2.2 Escalating investments in R&D by companies 3.2.3 Rising prevalence of cardiac and neurological disorders 3.2.4 Regulatory approval for advanced bioelectric devices 3.3 Market Restraint Analysis 3.3.1 Product recall
Follow Us:
3.3.2 Stringent government regulations 3.3.3 Lack of skilled professionals 3.4 Key Opportunities Prioritized 3.4.1 Key opportunities prioritized, by product 3.4.2 Key opportunities prioritized, by type 3.4.3 Key opportunities prioritized, by application 3.4.4 Key opportunities prioritized, by end-use 3.5 Electroceuticals/Bioelectric Medicine - SWOT Analysis, By Factor (Political & Legal, Economic And Technological) 3.6 Industry Analysis - Porter’s 3.7 Competitive Landscape: Market Share Analysis, 2016 Chapter 4 Electroceuticals/Bioelectric Medicine: Product Estimates & Trend Analysis 4.1 Electroceuticals/Bioelectric Medicine Market: Product Movement Analysis 4.2 Implantable Cardioverter Defibrillators 4.2.1 Implantable cardioverter defibrillators market, 2014 - 2025 (USD Million) 4.3 Cardiac Pacemakers 4.3.1 Cardiac pacemakers market, 2014 - 2025 (USD Million) 4.4 Cochlear Implants 4.4.1 Cochlear implants market, 2014 - 2025 (USD Million) 4.5 Spinal Cord Stimulators 4.5.1 Spinal cord stimulators market, 2014 - 2025 (USD Million) 4.6 Deep Brain Stimulators 4.6.1 Deep brain stimulators market, 2014 - 2025 (USD Million) 4.7 Transcutaneous Electrical Nerve Stimulators 4.7.1 Transcutaneous electrical nerve stimulators market, 2014 - 2025
Follow Us:
(USD Million) 4.8 Sacral Nerve Stimulators 4.8.1 Sacral nerve stimulators market, 2014 - 2025 (USD Million) 4.9 Vagus Nerve Stimulators 4.9.1 Vagus nerve stimulators market, 2014 - 2025 (USD Million) 4.10 Other Bioelectric Medicine 4.10.1 Other bioelectric medicine market, 2014 - 2025 (USD Million) Chapter 5 Electroceuticals/Bioelectric Medicine: Type Estimates & Trend Analysis 5.1 Electroceuticals/Bioelectric Medicine Market: Type Movement Analysis 5.2 Implantable Electroceutical Devices 5.2.1 Implantable electroceutical devices market, 2014 - 2025 (USD Million) 5.3 Noninvasive Electroceutical Devices 5.3.1 Noninvasive electroceutical devices market, 2014 - 2025 (USD Million) Chapter 6 Electroceuticals/Bioelectric Medicine: Application Estimates & Trend Analysis 6.1 Electroceuticals/Bioelectric Medicine Market: Application Movement Analysis 6.2 Arrhythmia 6.2.1 Arrhythmia market, 2014 - 2025 (USD Million) 6.3 Pain Management 6.3.1 Pain management market, 2014 - 2025 (USD Million) 6.4 Sensorineural Hearing Loss 6.4.1 Sensorineural hearing loss market, 2014 - 2025 (USD Million) 6.5 Parkinson’s disease
Follow Us:
6.5.1 Parkinson’s disease market, 2014 - 2025 (USD Million) 6.6 Tremor 6.6.1 Tremor market, 2014 - 2025 (USD Million) 6.7 Depression 6.7.1 Depression market, 2014 - 2025 (USD Million) 6.8 Treatment-resistant Depression 6.8.1 Treatment-resistant depression market, 2014 - 2025 (USD Million) 6.9 Epilepsy 6.9.1 Epilepsy market, 2014 - 2025 (USD Million) 6.10 Urinary and Fecal Incontinence 6.10.1 Urinary and fecal incontinence market, 2014 - 2025 (USD Million) 6.11 Others 6.11.1 Others market, 2014 - 2025 (USD Million) Chapter 7 Electroceuticals/Bioelectric Medicine: End-use Estimates & Trend Analysis 7.1 Electroceuticals/bioelectric medicine market: End-use movement analysis 7.2 Hospitals 7.2.1 Hospitals market, 2014 - 2025 (USD Million) 7.3 Others 7.3.1 Others market, 2014 - 2025 (USD Million) Chapter 8 Electroceuticals/Bioelectric Medicine: Regional Estimates & Trend Analysis, by Product, Type, Application, End Use 8.1 Electroceuticals/Bioelectric Medicine Market Share by Region, 2016 & 2025 8.2 North America 8.2.1 U.S.
Follow Us:
8.2.1.1 U.S. electroceuticals market, by product, 2014 - 2025 (USD Million) 8.2.1.2 U.S. electroceuticals market, by type, 2014 - 2025 (USD Million) 8.2.1.3 U.S. electroceuticals market, by application, 2014 - 2025 (USD Million) 8.2.1.4 U.S. electroceuticals market, by end-use, 2014 - 2025 (USD Million) 8.2.2 Canada 8.2.2.1 Canada electroceuticals market, by product, 2014 - 2025 (USD Million) 8.2.2.2 Canada electroceuticals market, by type, 2014 - 2025 (USD Million) 8.2.2.3 Canada electroceuticals market, by application, 2014 - 2025 (USD Million) 8.2.2.4 Canada electroceuticals market, by end-use, 2014 - 2025 (USD Million) 8.3 Europe 8.3.1 Germany 8.3.1.1 Germany electroceuticals market, by product, 2014 - 2025 (USD Million) 8.3.1.2 Germany electroceuticals market, by type, 2014 - 2025 (USD Million) 8.3.1.3 Germany electroceuticals market, by application, 2014 - 2025 (USD Million) 8.3.1.4 Germany electroceuticals market, by end-use, 2014 - 2025 (USD Million) 8.3.2 UK
Follow Us:
8.3.2.1 UK electroceuticals market, by product, 2014 - 2025 (USD Million) 8.3.2.2 UK electroceuticals market, by type, 2014 - 2025 (USD Million) 8.3.2.3 UK electroceuticals market, by application, 2014 - 2025 (USD Million) 8.3.2.4 UK electroceuticals market, by end-use, 2014 - 2025 (USD Million) 8.4 Asia Pacific 8.4.1 Japan 8.4.1.1 Japan electroceuticals market, by product, 2014 - 2025 (USD Million) 8.4.1.2 Japan electroceuticals market, by type, 2014 - 2025 (USD Million) 8.4.1.3 Japan electroceuticals market, by application, 2014 - 2025 (USD Million) 8.4.1.4 Japan electroceuticals market, by end-use, 2014 - 2025 (USD Million) 8.4.2 China 8.4.2.1 China electroceuticals market, by product, 2014 - 2025 (USD Million) 8.4.2.2 China electroceuticals market, by type, 2014 - 2025 (USD Million) 8.4.2.3 China electroceuticals market, by application, 2014 - 2025 (USD Million) 8.4.2.4 China electroceuticals market, by end-use, 2014 - 2025 (USD Million) 8.4.3 India
Follow Us:
8.4.3.1 India electroceuticals market, by product, 2014 - 2025 (USD Million) 8.4.3.2 India electroceuticals market, by type, 2014 - 2025 (USD Million) 8.4.3.3 India electroceuticals market, by application, 2014 - 2025 (USD Million) 8.4.3.4 India electroceuticals market, by end-use, 2014 - 2025 (USD Million) 8.5 Latin America 8.5.1 Brazil 8.5.1.1 Brazil electroceuticals market, by product, 2014 - 2025 (USD Million) 8.5.1.2 Brazil electroceuticals market, by type, 2014 - 2025 (USD Million) 8.5.1.3 Brazil electroceuticals market, by application, 2014 - 2025 (USD Million) 8.5.1.4 Brazil electroceuticals market, by end-use, 2014 - 2025 (USD Million) 8.5.2 Mexico 8.5.2.1 Mexico electroceuticals market, by product, 2014 - 2025 (USD Million) 8.5.2.2 Mexico electroceuticals market, by type, 2014 - 2025 (USD Million) 8.5.2.3 Mexico electroceuticals market, by application, 2014 - 2025 (USD Million) 8.5.2.4 Mexico electroceuticals market, by end-use, 2014 - 2025 (USD Million) 8.6 MEA
Follow Us:
8.6.1 South Africa 8.6.1.1 South Africa electroceuticals market, by product, 2014 - 2025 (USD Million) 8.6.1.2 South Africa electroceuticals market, by type, 2014 - 2025 (USD Million) 8.6.1.3 South Africa electroceuticals market, by application, 2014 - 2025 (USD Million) 8.6.1.4 South Africa electroceuticals market, by end-use, 2014 - 2025 (USD Million) Chapter 9 Competitive Landscape 9.1 Company Profiles 9.1.1 Medtronic 9.1.1.1 Company overview 9.1.1.2 Financial performance 9.1.1.3 Product benchmarking 9.1.1.4 Strategic initiatives 9.1.2 St. Jude Medical, Inc. 9.1.2.1 Company overview 9.1.2.2 Financial performance 9.1.2.3 Product benchmarking 9.1.2.4 Strategic initiatives 9.1.3 Boston Scientific Corporation 9.1.3.1 Company overview 9.1.3.2 Financial performance 9.1.3.3 Product benchmarking 9.1.3.4 Strategic initiatives 9.1.4 Cochlear Ltd
Follow Us:
9.1.4.1 Company overview 9.1.4.2 Financial performance 9.1.4.3 Product benchmarking 9.1.4.4 Strategic initiatives 9.1.5 Sonova; LivaNova PLC 9.1.5.1 Company overview 9.1.5.2 Financial performance 9.1.5.3 Product benchmarking 9.1.5.4 Strategic initiatives 9.1.6 Biotronik 9.1.6.1 Company overview 9.1.6.2 Financial performance 9.1.6.3 Product benchmarking 9.1.6.4 Strategic initiatives 9.1.7 Nevro Corp. 9.1.7.1 Company overview 9.1.7.2 Financial performance 9.1.7.3 Product benchmarking 9.1.7.4 Strategic initiatives 9.1.8 Second Sight 9.1.8.1 Company overview 9.1.8.2 Financial performance 9.1.8.3 Product benchmarking 9.1.8.4 Strategic initiatives 9.1.9 electroCore LLC. 9.1.9.1 Company overview 9.1.9.2 Financial performance
Follow Us:
9.1.9.3 Product benchmarking 9.1.9.4 Strategic initiatives About Grand View Research, Inc.:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: sales@grandviewresearch.com For More Information: http://www.grandviewresearch.com
Follow Us: